OTC:RAJAF | Cash Flow Statement | TFA Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2021-12-31 to 2025-12-31
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2023-12-31$901,171.00$55,717.00-$1.23M-$1.22M$1.22M$48,030.00
2022-12-31-$77,046.00-$110,817.00-$1,456.00$6,970.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$154,822.00-$35,845.00
2024-12-31-$226,258.00$312,006.00$349,237.00-$305,637.00
2023-12-31$751,609.00$56,757.00$359,724.00$319,487.00-$319,820.00-$32,208.00
2022-12-31-$720,093.00$24,490.00-$321,378.00$475.00-$475.00$245,787.00
2021-12-31-$491,006.00-$365,363.00$100,000.00-$110,815.00$574,504.00